{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:35:11Z","timestamp":1793140511935,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T00:00:00Z","timestamp":1580428800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T00:00:00Z","timestamp":1580428800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005416","name":"Norges Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["179342 and 192534"],"award-info":[{"award-number":["179342 and 192534"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005036","name":"Universitetet i Bergen","doi-asserted-by":"publisher","award":["salaries"],"award-info":[{"award-number":["salaries"]}],"id":[{"id":"10.13039\/501100005036","id-type":"DOI","asserted-by":"publisher"}]},{"name":"St John's Research Institute","award":["salaries and lab support"],"award-info":[{"award-number":["salaries and lab support"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      The goal of tuberculosis elimination put forward in the End TB Strategy prioritizes diagnosis and treatment of incipient and subclinical TB, recently defined by key stakeholders as\n                      <jats:italic>\u201casymptomatic, early pre-clinical disease during which pathology evolves\u201d<\/jats:italic>\n                      . Regarded as indicative of a high risk of TB progression, considerable efforts have been made to identify these cases through exploration of biomarkers. The present study aimed to evaluate simple scoring systems for TB exposure as screening tools for subclinical TB, the only identifiable of the incipient and subclinical disease states, in a contact investigation (CI) setting of low HIV-prevalence.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Nested within a large prospective study in household contacts (HHCs) of smear positive pulmonary TB cases in South-India conducted 2010\u20132012, we assessed 1) the association between the Tuberculosis Contact Score (TCS) and the Infectivity Score, with established tools for\n                      <jats:italic>Mycobacterium tuberculosis (Mtb)<\/jats:italic>\n                      infection, corrected for established TB risk factors, and 2) the capability of the TB exposure scores to identify subclinical TB defined by\n                      <jats:italic>Mtb-<\/jats:italic>\n                      culture positivity in sputum or gastric aspirate (subjects &lt;\u20095\u2009years) specimen.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 525 HHCs, 29 were\n                      <jats:italic>Mtb<\/jats:italic>\n                      -culture positive and 96.6% of these asymptomatic. The TCS and the Infectivity Score associated with positive Tuberculin Skin Test and QuantiFeron TB-Gold In-tube assay (QFT) results in multivariate analyses (TCS: OR\n                      <jats:sub>TST<\/jats:sub>\n                      1.16, 95% CI: 1.01, 1.33; OR\n                      <jats:sub>QFT<\/jats:sub>\n                      1.33 95% CI: 1.16, 1.51. Infectivity Score: OR\n                      <jats:sub>TST<\/jats:sub>\n                      1.39, 95% CI: 1.10, 1.76; OR\n                      <jats:sub>QFT<\/jats:sub>\n                      1.41 95% CI: 1.16, 1.71). The Infectivity Score showed a moderate capability to identify subclinical TB (AUC of 0.61, 95% CI: 0.52, 0.70).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Although our results did not identify an easily applicable screening tool for subclinical TB, the present study indicates that focusing on TB-related symptoms in CI settings may be of limited value for early identification of HHCs with high risk for TB progression.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-020-4800-y","type":"journal-article","created":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T14:02:59Z","timestamp":1580479379000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Identification of subclinical tuberculosis in household contacts using exposure scores and contact investigations"],"prefix":"10.1186","volume":"20","author":[{"given":"Gry Klouman","family":"Bekken","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Ritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumithra","family":"Selvam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson","family":"Jesuraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneke C.","family":"Hesseling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Mark","family":"Doherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harleen M. S.","family":"Grewal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Vaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8187-775X","authenticated-orcid":false,"given":"Synne","family":"Jenum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,31]]},"reference":[{"key":"4800_CR1","volume-title":"Global tuberculosis report 2019","author":"WHO","year":"2019","unstructured":"WHO. Global tuberculosis report 2019. Geneva: World Health Organization; 2019. Contract No.: ISBN 978-92-4-156571-4"},{"key":"4800_CR2","volume-title":"The Global Plan to Stop TB 2006\u20132015","author":"WHO","year":"2006","unstructured":"WHO. The Global Plan to Stop TB 2006\u20132015. 2006."},{"key":"4800_CR3","volume-title":"Framework for Effective Tuberculosis Control","author":"WHO","year":"1994","unstructured":"WHO. WHO Tuberculosis Programme. In: Framework for Effective Tuberculosis Control; 1994."},{"key":"4800_CR4","volume-title":"Global tuberculosis report 2018","author":"WHO","year":"2018","unstructured":"WHO. Global tuberculosis report 2018. Geneva: World Health Organization; 2018. Report No.: ISBN 978-92-4-156564-6"},{"key":"4800_CR5","volume-title":"The End TB Strategy. Global strategy and targets for tuberculosis prevention, care and control after 2015","author":"WHO","year":"2014","unstructured":"WHO. In: Organization WH, editor. The End TB Strategy. Global strategy and targets for tuberculosis prevention, care and control after 2015. Geneva: World Health Organization; 2014."},{"issue":"4","key":"4800_CR6","doi-asserted-by":"publisher","first-page":"1800946","DOI":"10.1183\/13993003.00946-2018","volume":"52","author":"Sandra V. Kik","year":"2018","unstructured":"Kik SV, Schumacher S, Cirillo DM, Churchyard G, Boehme C, Goletti D, et al. An evaluation framework for new tests that predict progression from tuberculosis infection to clinical disease. Eur Respir J. 2018;52(4), 1800946.","journal-title":"European Respiratory Journal"},{"issue":"1","key":"4800_CR7","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1183\/09031936.00070812","volume":"41","author":"GJ Fox","year":"2013","unstructured":"Fox GJ, Barry SE, Britton WJ, Marks GB. Contact investigation for tuberculosis: a systematic review and meta-analysis. Eur Respir J. 2013;41(1):140\u201356.","journal-title":"Eur Respir J"},{"key":"4800_CR8","volume-title":"Recommendations for investigating contacts of persons with infectious TB in low- and middle-income countries","author":"WHO","year":"2012","unstructured":"WHO. Recommendations for investigating contacts of persons with infectious TB in low- and middle-income countries. Geneva: World Health Organization; 2012."},{"issue":"33","key":"4800_CR9","doi-asserted-by":"publisher","first-page":"13980","DOI":"10.1073\/pnas.0901720106","volume":"106","author":"LJ Abu-Raddad","year":"2009","unstructured":"Abu-Raddad LJ, Sabatelli L, Achterberg JT, Sugimoto JD, Longini IM Jr, Dye C, et al. Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics. Proc Natl Acad Sci U S A. 2009;106(33):13980\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"4800_CR10","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1146\/annurev-publhealth-031912-114431","volume":"34","author":"Christopher Dye","year":"2013","unstructured":"Dye C, Glaziou P, Floyd K, Raviglione M. Prospects for Tuberculosis Elimination. Annu Rev Public Health. 2012;34(1):271\u201386.","journal-title":"Annual Review of Public Health"},{"issue":"22","key":"4800_CR11","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1056\/NEJMra1405427","volume":"372","author":"H Getahun","year":"2015","unstructured":"Getahun H, Matteelli A, Chaisson RE, Raviglione M. Latent mycobacterium tuberculosis infection. N Engl J Med. 2015;372(22):2127\u201335.","journal-title":"N Engl J Med"},{"issue":"1","key":"4800_CR12","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1378\/chest.11-3157","volume":"142","author":"R Diel","year":"2012","unstructured":"Diel R, Loddenkemper R, Nienhaus A. Predictive value of interferon-gamma release assays and tuberculin skin testing for progression from latent TB infection to disease state: a meta-analysis. Chest. 2012;142(1):63\u201375.","journal-title":"Chest"},{"issue":"1","key":"4800_CR13","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S1473-3099(11)70210-9","volume":"12","author":"MX Rangaka","year":"2012","unstructured":"Rangaka MX, Wilkinson KA, Glynn JR, Ling D, Menzies D, Mwansa-Kambafwile J, et al. Predictive value of interferon-gamma release assays for incident active tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12(1):45\u201355.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"4800_CR14","doi-asserted-by":"publisher","first-page":"e00021","DOI":"10.1128\/CMR.00021-18","volume":"31","author":"Paul K. Drain","year":"2018","unstructured":"Drain PK, Bajema KL, Dowdy D, Dheda K, Naidoo K, Schumacher SG, et al. Incipient and Subclinical Tuberculosis: a Clinical Review of Early Stages and Progression of Infection. Clin Microbiol Rev. 2018;31(4).","journal-title":"Clinical Microbiology Reviews"},{"key":"4800_CR15","volume-title":"Tuberculosis diagnostics: which target product profiles should be prioritised? Eur Respir J","author":"SV Kik","year":"2014","unstructured":"Kik SV, Denkinger CM, Casenghi M, Vadnais C, Pai M. Tuberculosis diagnostics: which target product profiles should be prioritised? Eur Respir J; 2014."},{"issue":"10","key":"4800_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002152","volume":"13","author":"RM Houben","year":"2016","unstructured":"Houben RM, Dodd PJ. The global burden of latent tuberculosis infection: a re-estimation using mathematical Modelling. PLoS Med. 2016;13(10):e1002152.","journal-title":"PLoS Med"},{"key":"4800_CR17","doi-asserted-by":"crossref","unstructured":"Zak DE, Penn-Nicholson A, Scriba TJ, Thompson E, Suliman S, Amon LM, et al. A blood RNA signature for tuberculosis disease risk: a prospective cohort study. Lancet. 2016.","DOI":"10.1016\/S0140-6736(15)01316-1"},{"issue":"6","key":"4800_CR18","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1183\/13993003.01012-2016","volume":"48","author":"E Petruccioli","year":"2016","unstructured":"Petruccioli E, Scriba TJ, Petrone L, Hatherill M, Cirillo DM, Joosten SA, et al. Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis. Eur Respir J. 2016;48(6):1751\u201363.","journal-title":"Eur Respir J"},{"key":"4800_CR19","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.smim.2018.10.001","volume":"39","author":"HA Fletcher","year":"2018","unstructured":"Fletcher HA. Systems approaches to correlates of protection and progression to TB disease. Semin Immunol. 2018;39:81\u20137.","journal-title":"Semin Immunol"},{"issue":"9979","key":"4800_CR20","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1016\/S0140-6736(15)60570-0","volume":"385","author":"M Uplekar","year":"2015","unstructured":"Uplekar M, Weil D, Lonnroth K, Jaramillo E, Lienhardt C, Dias HM, et al. WHO's new end TB strategy. Lancet. 2015;385(9979):1799\u2013801.","journal-title":"Lancet."},{"issue":"1","key":"4800_CR21","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1093\/ije\/dyp308","volume":"39","author":"K Lonnroth","year":"2010","unstructured":"Lonnroth K, Williams BG, Cegielski P, Dye C. A consistent log-linear relationship between tuberculosis incidence and body mass index. Int J Epidemiol. 2010;39(1):149\u201355.","journal-title":"Int J Epidemiol"},{"issue":"11","key":"4800_CR22","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1016\/S1473-3099(17)30447-4","volume":"17","author":"MJ Saunders","year":"2017","unstructured":"Saunders MJ, Wingfield T, Tovar MA, Baldwin MR, Datta S, Zevallos K, et al. A score to predict and stratify risk of tuberculosis in adult contacts of tuberculosis index cases: a prospective derivation and external validation cohort study. Lancet Infect Dis. 2017;17(11):1190\u20139.","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"4800_CR23","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.5588\/ijtld.12.0027","volume":"16","author":"AM Mandalakas","year":"2012","unstructured":"Mandalakas AM, Kirchner HL, Lombard C, Walzl G, Grewal HM, Gie RP, et al. Well-quantified tuberculosis exposure is a reliable surrogate measure of tuberculosis infection. Int J Tuberc Lung Dis. 2012;16(8):1033\u20139.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"10","key":"4800_CR24","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1136\/thx.2007.085340","volume":"64","author":"AC Hesseling","year":"2009","unstructured":"Hesseling AC, Mandalakas AM, Kirchner HL, Chegou NN, Marais BJ, Stanley K, et al. Highly discordant T cell responses in individuals with recent exposure to household tuberculosis. Thorax. 2009;64(10):840\u20136.","journal-title":"Thorax"},{"issue":"10","key":"4800_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0164181","volume":"11","author":"TM Perez-Porcuna","year":"2016","unstructured":"Perez-Porcuna TM, Pereira-da-Silva HD, Ascaso C, Malheiro A, Buhrer S, Martinez-Espinosa F, et al. Prevalence and diagnosis of latent tuberculosis infection in Young children in the absence of a gold standard. PLoS One. 2016;11(10):e0164181.","journal-title":"PLoS One"},{"issue":"9","key":"4800_CR26","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1164\/rccm.200505-748OC","volume":"172","author":"H Shams","year":"2005","unstructured":"Shams H, Weis SE, Klucar P, Lalvani A, Moonan PK, Pogoda JM, et al. Enzyme-linked immunospot and tuberculin skin testing to detect latent tuberculosis infection. Am J Respir Crit Care Med. 2005;172(9):1161\u20138.","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"4800_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0105003","volume":"9","author":"HV Tieu","year":"2014","unstructured":"Tieu HV, Suntarattiwong P, Puthanakit T, Chotpitayasunondh T, Chokephaibulkit K, Sirivichayakul S, et al. Comparing interferon-gamma release assays to tuberculin skin test in Thai children with tuberculosis exposure. PLoS One. 2014;9(8):e105003.","journal-title":"PLoS One"},{"issue":"5","key":"4800_CR28","first-page":"724","volume":"69","author":"JB Shaw","year":"1954","unstructured":"Shaw JB, Wynn-Williams N. Infectivity of pulmonary tuberculosis in relation to sputum status. Am Rev Tuberc. 1954;69(5):724\u201332.","journal-title":"Am Rev Tuberc"},{"issue":"9200","key":"4800_CR29","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S0140-6736(99)04402-5","volume":"355","author":"MA Espinal","year":"2000","unstructured":"Espinal MA, Perez EN, Baez J, Henriquez L, Fernandez K, Lopez M, et al. Infectiousness of mycobacterium tuberculosis in HIV-1-infected patients with tuberculosis: a prospective study. Lancet. 2000;355(9200):275\u201380.","journal-title":"Lancet"},{"issue":"4","key":"4800_CR30","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1136\/thx.2009.124891","volume":"65","author":"J Mutsvangwa","year":"2010","unstructured":"Mutsvangwa J, Millington KA, Chaka K, Mavhudzi T, Cheung YB, Mason PR, et al. Identifying recent mycobacterium tuberculosis transmission in the setting of high HIV and TB burden. Thorax. 2010;65(4):315\u201320.","journal-title":"Thorax"},{"issue":"4","key":"4800_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0018206","volume":"6","author":"K Shanaube","year":"2011","unstructured":"Shanaube K, Hargreaves J, Fielding K, Schaap A, Lawrence KA, Hensen B, et al. Risk factors associated with positive QuantiFERON-TB gold in-tube and tuberculin skin tests results in Zambia and South Africa. PLoS One. 2011;6(4):e18206.","journal-title":"PLoS One"},{"issue":"9","key":"4800_CR32","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1111\/tmi.12534","volume":"20","author":"I Onozaki","year":"2015","unstructured":"Onozaki I, Law I, Sismanidis C, Zignol M, Glaziou P, Floyd K. National tuberculosis prevalence surveys in Asia, 1990-2012: an overview of results and lessons learned. Trop Med Int Health : TM IH. 2015;20(9):1128\u201345.","journal-title":"Trop Med Int Health : TM IH"},{"key":"4800_CR33","unstructured":"International Institute for Population Sciences (IIPS) and Macro International. National Family Health Survey (NFHS-3), India, 2005-06: Andhra Pradesh. Mumbai: IIPS; 2008."},{"key":"4800_CR34","unstructured":"NACO. Annual HIV Sentinel Surveillance. Country Report 2008-2009. Government of India: Government of India; 2011 [Available from: http:\/\/www.naco.gov.in\/sites\/default\/files\/HIV%20Sentinel%20Surveillance%20India%20Country%20Report%2C%202008-09.pdf. Accessed 16 Dec 2019."},{"key":"4800_CR35","unstructured":"Go I. Concepts and definitions: Government of India CoId; 2001."},{"issue":"5","key":"4800_CR36","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1055\/s-0028-1085700","volume":"29","author":"K Lonnroth","year":"2008","unstructured":"Lonnroth K, Raviglione M. Global epidemiology of tuberculosis: prospects for control. Semin Respir Crit Care Med. 2008;29(5):481\u201391.","journal-title":"Semin Respir Crit Care Med"},{"key":"4800_CR37","volume-title":"High-priority target product profiles for new tuberculosis diagnostics: report of a consensus meeting","author":"WHO","year":"2014","unstructured":"WHO. High-priority target product profiles for new tuberculosis diagnostics: report of a consensus meeting. Geneva: World Health Organization; 2014. Report No.: WHO_HTM_TB_2014.18"},{"key":"4800_CR38","volume-title":"Guidelines on the management of latent tuberculosis infection","author":"WHO","year":"2015","unstructured":"WHO. In: Organization WH, editor. Guidelines on the management of latent tuberculosis infection. Geneva: World Health Organization; 2015."},{"key":"4800_CR39","unstructured":"WHO. Global tuberculosis report 2013. Geneva, World Health Organization; 2013. Report No.: ISBN 9789241564656"},{"key":"4800_CR40","unstructured":"Government of India CTD. TB India 2014. Revised National TB Control Programme. Annual Status Report. In: Welfare MoHaF, editor. www.tbcindia.nic.in: Government of India; 2014. Accessed 16 Dec 2019."},{"issue":"7","key":"4800_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0069730","volume":"8","author":"J Singh","year":"2013","unstructured":"Singh J, Sankar MM, Kumar S, Gopinath K, Singh N, Mani K, et al. Incidence and prevalence of tuberculosis among household contacts of pulmonary tuberculosis patients in a peri-urban population of South Delhi. India PLoS One. 2013;8(7):e69730.","journal-title":"India PLoS One"},{"issue":"5","key":"4800_CR42","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.tim.2009.02.005","volume":"17","author":"DB Young","year":"2009","unstructured":"Young DB, Gideon HP, Wilkinson RJ. Eliminating latent tuberculosis. Trends Microbiol. 2009;17(5):183\u20138.","journal-title":"Trends Microbiol"},{"issue":"12","key":"4800_CR43","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/nrmicro2236","volume":"7","author":"CE Barry III","year":"2009","unstructured":"Barry CE III, Boshoff HI, Dartois V, Dick T, Ehrt S, Flynn J, et al. The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat Rev Microbiol. 2009;7(12):845\u201355.","journal-title":"Nat Rev Microbiol"},{"issue":"9785","key":"4800_CR44","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0140-6736(10)62173-3","volume":"378","author":"SD Lawn","year":"2011","unstructured":"Lawn SD, Zumla AI. Tuberculosis Lancet. 2011;378(9785):57\u201372.","journal-title":"Tuberculosis Lancet"},{"key":"4800_CR45","first-page":"313","volume":"6","author":"KP Fennelly","year":"2015","unstructured":"Fennelly KP, Jones-Lopez EC. Quantity and quality of inhaled dose predicts immunopathology in tuberculosis. Front Immunol. 2015;6:313.","journal-title":"Front Immunol"},{"issue":"10","key":"4800_CR46","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1164\/rccm.200511-1809SO","volume":"173","author":"BJ Marais","year":"2006","unstructured":"Marais BJ, Gie RP, Schaaf HS, Beyers N, Donald PR, Starke JR. Childhood pulmonary tuberculosis: old wisdom and new challenges. Am J Respir Crit Care Med. 2006;173(10):1078\u201390.","journal-title":"Am J Respir Crit Care Med"},{"key":"4800_CR47","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/1471-2458-10-263","volume":"10","author":"A Pradhan","year":"2010","unstructured":"Pradhan A, Kielmann K, Gupte H, Bamne A, Porter JD, Rangan S. What 'outliers' tell us about missed opportunities for tuberculosis control: a cross-sectional study of patients in Mumbai. India BMC Public Health. 2010;10:263.","journal-title":"India BMC Public Health"},{"issue":"8","key":"4800_CR48","first-page":"569","volume":"3","author":"A Tamhane","year":"2012","unstructured":"Tamhane A, Ambe G, Vermund SH, Kohler CL, Karande A, Sathiakumar N. Pulmonary tuberculosis in Mumbai, India: factors responsible for patient and treatment delays. Int J Prev Med. 2012;3(8):569\u201380.","journal-title":"Int J Prev Med"},{"issue":"12","key":"4800_CR49","first-page":"1480","volume":"4","author":"BK Behera","year":"2013","unstructured":"Behera BK, Jain RB, Gupta KB, Goel MK. Extent of delay in diagnosis in new smear positive patients of pulmonary tuberculosis attending tertiary care hospital. Int J Prev Med. 2013;4(12):1480\u20135.","journal-title":"Int J Prev Med"},{"issue":"1","key":"4800_CR50","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12890-017-0551-y","volume":"17","author":"F Getnet","year":"2017","unstructured":"Getnet F, Demissie M, Assefa N, Mengistie B, Worku A. Delay in diagnosis of pulmonary tuberculosis in low-and middle-income settings: systematic review and meta-analysis. BMC Pulm Med. 2017;17(1):202.","journal-title":"BMC Pulm Med"},{"key":"4800_CR51","first-page":"64","volume":"116","author":"S Kaur","year":"2002","unstructured":"Kaur S, Faridi MM, Agarwal KN. BCG vaccination reaction in low birth weight infants. Indian J Med Res. 2002;116:64\u20139.","journal-title":"Indian J Med Res"},{"issue":"1","key":"4800_CR52","doi-asserted-by":"publisher","first-page":"e000304","DOI":"10.1136\/bmjresp-2018-000304","volume":"5","author":"S Jenum","year":"2018","unstructured":"Jenum S, Sumithra S, Nelson J, Christian R, Anneke CH, Vicky C, et al. Incidence of tuberculosis and the influence of surveillance strategy on tuberculosis case-finding and all-cause mortality: a cluster randomised trial in Indian neonates vaccinated with BCG. BMJ open respiratory research. 2018;5(1):e000304.","journal-title":"BMJ open respiratory research"},{"key":"4800_CR53","first-page":"670167","volume":"2015","author":"K Khaparde","year":"2015","unstructured":"Khaparde K, Jethani P, Dewan PK, Nair SA, Deshpande MR, Satyanarayana S, et al. Evaluation of TB case finding through systematic contact investigation, Chhattisgarh. India Tuberculosis research and treatment. 2015;2015:670167.","journal-title":"India Tuberculosis research and treatment"},{"issue":"9","key":"4800_CR54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0162090","volume":"11","author":"D Nair","year":"2016","unstructured":"Nair D, Rajshekhar N, Klinton JS, Watson B, Velayutham B, Tripathy JP, et al. Household contact screening and yield of tuberculosis cases-a clinic based study in Chennai. South India PLoS One. 2016;11(9):e0162090.","journal-title":"South India PLoS One"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-4800-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-020-4800-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-4800-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T19:10:49Z","timestamp":1611947449000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-4800-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,31]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["4800"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-4800-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.16912\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.16912\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.16912\/v2","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,31]]},"assertion":[{"value":"24 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the institutional ethical review board of the St John\u2019s National Academy of Health Sciences, Bangalore, an independent Ethics Committee contracted by Aeras, USA, and the Ministry of Health Screening Committee, Government of India (No. 5\/8\/9\/60\/2006-ECD-I dt. 10.11.2006). Participants (parents\/caretakers) gave written consent for enrolment. Also, ethical approval was obtained (Ref no: <b>2018\/1614 D)<\/b> from the Regional Committee for Medical and Health Research Ethics, Western-Norway (REK Vest)<b>.<\/b>","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"96"}}